Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Preclinical In-vivo Imaging System Market Size Growth Rate by Type
1.3.2 Optical Imaging System
1.3.3 Nuclear Imaging System
1.3.4 Micro MRI System
1.3.5 Micro CT System
1.3.6 Micro Ultrasound System
1.3.7 Photoacoustic and Magnetic Particle Imaging Systems
1.4 Market Segment by Application
1.4.1 Global Preclinical In-vivo Imaging System Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Veterinary Clinics
1.4.4 Laboratory
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Preclinical In-vivo Imaging System Production Value 2014-2025
2.1.2 Global Preclinical In-vivo Imaging System Production 2014-2025
2.1.3 Global Preclinical In-vivo Imaging System Capacity 2014-2025
2.1.4 Global Preclinical In-vivo Imaging System Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Preclinical In-vivo Imaging System Market Size CAGR of Key Regions
2.2.2 Global Preclinical In-vivo Imaging System Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Preclinical In-vivo Imaging System Capacity by Manufacturers
3.1.2 Global Preclinical In-vivo Imaging System Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Preclinical In-vivo Imaging System Revenue by Manufacturers (2014-2019)
3.2.2 Preclinical In-vivo Imaging System Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Preclinical In-vivo Imaging System Market Concentration Ratio (CR5 and HHI)
3.3 Preclinical In-vivo Imaging System Price by Manufacturers
3.4 Key Manufacturers Preclinical In-vivo Imaging System Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Preclinical In-vivo Imaging System Market
3.6 Key Manufacturers Preclinical In-vivo Imaging System Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Optical Imaging System Production and Production Value (2014-2019)
4.1.2 Nuclear Imaging System Production and Production Value (2014-2019)
4.1.3 Micro MRI System Production and Production Value (2014-2019)
4.1.4 Micro CT System Production and Production Value (2014-2019)
4.1.5 Micro Ultrasound System Production and Production Value (2014-2019)
4.1.6 Photoacoustic and Magnetic Particle Imaging Systems Production and Production Value (2014-2019)
4.2 Global Preclinical In-vivo Imaging System Production Market Share by Type
4.3 Global Preclinical In-vivo Imaging System Production Value Market Share by Type
4.4 Preclinical In-vivo Imaging System Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Preclinical In-vivo Imaging System Consumption by Application
6 Production by Regions
6.1 Global Preclinical In-vivo Imaging System Production (History Data) by Regions 2014-2019
6.2 Global Preclinical In-vivo Imaging System Production Value (History Data) by Regions
6.3 North America
6.3.1 North AmericaPreclinical In-vivo Imaging System Production Growth Rate 2014-2019
6.3.2 North America Preclinical In-vivo Imaging System Production Value Growth Rate 2014-2019
6.3.3 Key Players in North America
6.3.4 North America Preclinical In-vivo Imaging System Import & Export
6.4 Europe
6.4.1 Europe Preclinical In-vivo Imaging System Production Growth Rate 2014-2019
6.4.2 Europe Preclinical In-vivo Imaging System Production Value Growth Rate 2014-2019
6.4.3 Key Players in Europe
6.4.4 Europe Preclinical In-vivo Imaging System Import & Export
6.5 China
6.5.1 China Preclinical In-vivo Imaging System Production Growth Rate 2014-2019
6.5.2 China Preclinical In-vivo Imaging System Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Preclinical In-vivo Imaging System Import & Export
6.6 Japan
6.6.1 Japan Preclinical In-vivo Imaging System Production Growth Rate 2014-2019
6.6.2 Japan Preclinical In-vivo Imaging System Production Value Growth Rate 2014-2019
6.6.3 Key Players in Japan
6.6.4 Japan Preclinical In-vivo Imaging System Import & Export
7 Preclinical In-vivo Imaging System Consumption by Regions
7.1 Global Preclinical In-vivo Imaging System Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Preclinical In-vivo Imaging System Consumption by Type
7.2.2 North America Preclinical In-vivo Imaging System Consumption by Application
7.2.3 North America Preclinical In-vivo Imaging System Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Preclinical In-vivo Imaging System Consumption by Type
7.3.2 Europe Preclinical In-vivo Imaging System Consumption by Application
7.3.3 Europe Preclinical In-vivo Imaging System Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Preclinical In-vivo Imaging System Consumption by Type
7.4.2 Asia Pacific Preclinical In-vivo Imaging System Consumption by Application
7.4.3 Asia Pacific Preclinical In-vivo Imaging System Consumption by Regions
7.4.4 China
7.4.5 Japan
7.4.6 South Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Preclinical In-vivo Imaging System Consumption by Type
7.5.2 Central & South America Preclinical In-vivo Imaging System Consumption by Application
7.5.3 Central & South America Preclinical In-vivo Imaging System Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Preclinical In-vivo Imaging System Consumption by Type
7.6.2 Middle East and Africa Preclinical In-vivo Imaging System Consumption by Application
7.6.3 Central & South America Preclinical In-vivo Imaging System Consumption by Countries
7.6.4 Turkey
7.6.5 GCC Countries
7.6.6 Egypt
7.6.7 South Africa
8 Company Profiles
8.1 Siemens A.G.
8.1.1 Siemens A.G. Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Preclinical In-vivo Imaging System
8.1.4 Preclinical In-vivo Imaging System Product Introduction
8.1.5 Siemens A.G. Recent Development
8.2 General Electric(GE)
8.2.1 General Electric(GE) Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Preclinical In-vivo Imaging System
8.2.4 Preclinical In-vivo Imaging System Product Introduction
8.2.5 General Electric(GE) Recent Development
8.3 Agilent Technologies
8.3.1 Agilent Technologies Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Preclinical In-vivo Imaging System
8.3.4 Preclinical In-vivo Imaging System Product Introduction
8.3.5 Agilent Technologies Recent Development
8.4 FUJIFILM VisualSonics
8.4.1 FUJIFILM VisualSonics Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Preclinical In-vivo Imaging System
8.4.4 Preclinical In-vivo Imaging System Product Introduction
8.4.5 FUJIFILM VisualSonics Recent Development
8.5 Aspect Imaging
8.5.1 Aspect Imaging Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Preclinical In-vivo Imaging System
8.5.4 Preclinical In-vivo Imaging System Product Introduction
8.5.5 Aspect Imaging Recent Development
8.6 Biospace Lab SA
8.6.1 Biospace Lab SA Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Preclinical In-vivo Imaging System
8.6.4 Preclinical In-vivo Imaging System Product Introduction
8.6.5 Biospace Lab SA Recent Development
8.7 Bruker Corporation
8.7.1 Bruker Corporation Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Preclinical In-vivo Imaging System
8.7.4 Preclinical In-vivo Imaging System Product Introduction
8.7.5 Bruker Corporation Recent Development
8.8 LI-COR Biosciences
8.8.1 LI-COR Biosciences Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Preclinical In-vivo Imaging System
8.8.4 Preclinical In-vivo Imaging System Product Introduction
8.8.5 LI-COR Biosciences Recent Development
8.9 Mesoso Ltd.
8.9.1 Mesoso Ltd. Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Preclinical In-vivo Imaging System
8.9.4 Preclinical In-vivo Imaging System Product Introduction
8.9.5 Mesoso Ltd. Recent Development
8.10 MIlabs BV
8.10.1 MIlabs BV Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Preclinical In-vivo Imaging System
8.10.4 Preclinical In-vivo Imaging System Product Introduction
8.10.5 MIlabs BV Recent Development
8.11 MR Solutions Ltd
8.12 PerkinElmer
8.13 TriFoil Imaging
9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Preclinical In-vivo Imaging System Capacity, Production Forecast 2019-2025
9.1.2 Global Preclinical In-vivo Imaging System Production Value Forecast 2019-2025
9.2 Preclinical In-vivo Imaging System Production and Production Value Forecast by Regions
9.2.1 Global Preclinical In-vivo Imaging System Production Value Forecast by Regions
9.2.2 Global Preclinical In-vivo Imaging System Production Forecast by Regions
9.3 Preclinical In-vivo Imaging System Key Producers Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Preclinical In-vivo Imaging System Production Forecast by Type
9.4.2 Global Preclinical In-vivo Imaging System Production Value Forecast by Type
10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Preclinical In-vivo Imaging System Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Preclinical In-vivo Imaging System Consumption Forecast by Countries 2019-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Preclinical In-vivo Imaging System Consumption Forecast by Countries 2019-2025
10.4.2 France
10.4.3 UK
10.4.4 Italy
10.4.5 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Preclinical In-vivo Imaging System Consumption Forecast by Regions 2019-2025
10.5.2 Japan
10.5.3 South Korea
10.5.4 India
10.5.5 Australia
10.5.6 Indonesia
10.5.7 Thailand
10.5.8 Malaysia
10.5.9 Philippines
10.5.10 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Preclinical In-vivo Imaging System Consumption Forecast by Country 2019-2025
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Preclinical In-vivo Imaging System Consumption Forecast by Countries 2019-2025
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Preclinical In-vivo Imaging System Sales Channels
11.2.2 Preclinical In-vivo Imaging System Distributors
11.3 Preclinical In-vivo Imaging System Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
【掲載企業】
Siemens A.G.、General Electric(GE)、Agilent Technologies、FUJIFILM VisualSonics、Aspect Imaging、Biospace Lab SA、Bruker Corporation、LI-COR Biosciences、Mesoso Ltd.、MIlabs BV、MR Solutions Ltd、PerkinElmer、TriFoil Imaging
【免責事項】
https://www.globalresearch.jp/disclaimer